Avid Bioservices, Inc. (CDMO)
Largest Insider Buys in Sector
CDMO Stock Price History Chart
CDMO Stock Performance
About Avid Bioservices, Inc.
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides …
Insider Activity of Avid Bioservices, Inc.
Over the last 12 months, insiders at Avid Bioservices, Inc. have bought $336,770 and sold $470,528 worth of Avid Bioservices, Inc. stock.
On average, over the past 5 years, insiders at Avid Bioservices, Inc. have bought $1.4M and sold $2.53M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Hancock Richard B (director) — $336,770.
The last purchase of 23,000 shares for transaction amount of $134,734 was made by Hancock Richard B (director) on 2023‑12‑15.
List of Insider Buy and Sell Transactions, Avid Bioservices, Inc.
| 2024-10-14 | Sale | Chief Commercial Officer | 119 0.0002% | $10.15 | $1,208 | +0.35% | ||
| 2024-10-10 | Sale | President & CEO | 17,173 0.0242% | $10.05 | $172,589 | -0.05% | ||
| 2024-10-10 | Sale | Chief Commercial Officer | 982 0.0014% | $10.05 | $9,869 | -0.05% | ||
| 2024-10-10 | Sale | Chief Operations Officer | 2,232 0.0031% | $10.05 | $22,432 | -0.05% | ||
| 2024-07-15 | Sale | Chief Operations Officer | 530 0.001% | $8.36 | $4,431 | 0.00% | ||
| 2024-07-15 | Sale | Chief Commercial Officer | 307 0.0006% | $8.36 | $2,567 | 0.00% | ||
| 2024-07-12 | Sale | Chief Commercial Officer | 119 0.0002% | $8.05 | $958 | 0.00% | ||
| 2024-07-11 | Sale | Chief Operations Officer | 1,515 0.0026% | $7.54 | $11,423 | 0.00% | ||
| 2024-07-10 | Sale | President & CEO | 7,657 0.013% | $7.54 | $57,734 | 0.00% | ||
| 2024-07-10 | Sale | Chief Commercial Officer | 444 0.0008% | $7.54 | $3,348 | 0.00% | ||
| 2024-07-10 | Sale | Chief Operations Officer | 1,025 0.0017% | $7.54 | $7,729 | 0.00% | ||
| 2024-04-30 | Sale | President & CEO | 11,762 0.018% | $7.40 | $87,028 | +30.54% | ||
| 2024-04-30 | Sale | Chief Financial Officer | 2,826 0.0043% | $7.40 | $20,910 | +30.54% | ||
| 2024-04-30 | Sale | V. P., General Counsel | 1,643 0.0025% | $7.40 | $12,157 | +30.54% | ||
| 2024-04-30 | Sale | Chief Commercial Officer | 1,233 0.0019% | $7.40 | $9,122 | +30.54% | ||
| 2024-04-30 | Sale | Chief Operations Officer | 1,114 0.0017% | $7.40 | $8,243 | +30.54% | ||
| 2024-01-12 | Sale | Chief Commercial Officer | 274 0.0005% | $6.77 | $1,855 | +28.70% | ||
| 2024-01-10 | Sale | Chief Financial Officer | 2,408 0.0037% | $6.17 | $14,857 | +25.76% | ||
| 2024-01-10 | Sale | V. P., General Counsel | 1,346 0.0021% | $6.17 | $8,305 | +25.76% | ||
| 2024-01-10 | Sale | Chief Commercial Officer | 1,060 0.0016% | $6.17 | $6,540 | +25.76% |
Insider Historical Profitability
| Hart Daniel R | Chief Financial Officer | 82221 0.1289% | $10.95 | 1 | 19 | +109.89% |
| Hancock Richard B | director | 78760 0.1235% | $10.95 | 4 | 18 | +57.66% |
| SWARTZ ERIC S | director | 126000 0.1975% | $10.95 | 31 | 5 | <0.0001% |
| Bamforth Mark R | director | 126000 0.1975% | $10.95 | 4 | 1 | +65.61% |
| Carleone Joseph | director | 93956 0.1473% | $10.95 | 4 | 0 | +84.91% |
Institutional Investor Ownership
| State Street | $39.18M | 9.2 | 5.85M | +22.24% | +$7.13M | <0.01 | |
| BlackRock | $34.68M | 8.14 | 5.18M | -2% | -$708,337.39 | <0.01 | |
| Millennium Management LLC | $29.51M | 6.93 | 4.4M | +3.87% | +$1.1M | 0.02 | |
| The Vanguard Group | $24.56M | 5.77 | 3.67M | +1.31% | +$317,010.51 | <0.0001 | |
| AltraVue Capital LLC | $21.14M | 4.96 | 3.16M | +6.11% | +$1.22M | 2.29 |